Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung Cancer, Nonsmall Cell, Stage I”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00489008
What this trial is testing

SRS Study in Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 141
Testing effectiveness (Phase 2)Ended earlyNCT00470548
What this trial is testing

Abraxane and Alimta in Advanced Solid Tumors

Who this might be right for
Breast CancerLung CancerUnspecified Adult Solid Tumor, Protocol Specific
University of California, Davis 49
Early research (Phase 1)Study completedNCT00002625
What this trial is testing

Topotecan and Radiation Therapy in Treating Patients With Solid Tumors or Lymphoma

Who this might be right for
Esophageal CancerLung CancerLymphoma
National Cancer Institute (NCI) 5
Testing effectiveness (Phase 2)Study completedNCT00431015
What this trial is testing

Phase I/II Safety Study of IPI-504 in Relapsed/Refractory Stage IIIb, or Stage IV Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung Cancer
Infinity Pharmaceuticals, Inc. 88
Testing effectiveness (Phase 2)Active Not RecruitingNCT01770418
What this trial is testing

A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer

Who this might be right for
Lung Neoplasms
Proton Collaborative Group 32
Early research (Phase 1)UnknownNCT04193098
What this trial is testing

Study of Autologous Cytotoxic T Lymphocyte Immunotherapy Combination With PD-1 Inhibitor in the Advanced NSCLC

Who this might be right for
Non-small Cell Lung CancerSecond-line Treatment
Tianjin Medical University Cancer Institute and Hospital 10
Early research (Phase 1)Study completedNCT00002519
What this trial is testing

Paclitaxel Plus Radiation Therapy in Treating Patients With Untreated Stage III Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Vanderbilt-Ingram Cancer Center 6
Not applicableNot Yet RecruitingNCT06580665
What this trial is testing

Cryoablation with or Without Serplulimab in Treating Patients with Stage I-IIA Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Shanghai Chest Hospital 134
Early research (Phase 1)Study completedNCT00738452
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Stage I-IIIB Non-Small Cell Lung Cancer After Completion of Radiation Therapy Alone or Combined Radiation Therapy and Chemotherapy

Who this might be right for
Lung Cancer
City of Hope Medical Center 10
Testing effectiveness (Phase 2)Study completedNCT04271384
What this trial is testing

Stereotactic Ablative Radiotherapy With Nivolumab for Early-Stage Operable Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer Stage I
Hospital Israelita Albert Einstein 25
Testing effectiveness (Phase 2)Looking for participantsNCT07012031
What this trial is testing

Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation

Who this might be right for
Locally Advanced Lung Non-Small Cell CarcinomaMetastatic Lung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8+1 more
National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Study completedNCT00792701
What this trial is testing

S0720: Adjuvant Therapy Based on Gene Expression in Stage IA and IB Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
SWOG Cancer Research Network 85
Testing effectiveness (Phase 2)Study completedNCT00002577
What this trial is testing

Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 36
Testing effectiveness (Phase 2)Study completedNCT00923312
What this trial is testing

Trial of an RNActive®-Derived Cancer Vaccine in Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
CureVac 46
Early research (Phase 1)Ended earlyNCT00042835
What this trial is testing

Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer

Who this might be right for
Adenocarcinoma of the LungBronchoalveolar Cell Lung CancerLarge Cell Lung Cancer+3 more
National Cancer Institute (NCI) 48
Early research (Phase 1)Study completedNCT02535325
What this trial is testing

Methoxyamine Hydrochloride, Pemetrexed Disodium, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIIA-IV Non-small Cell Lung Cancer

Who this might be right for
Locally Advanced Lung Non-Squamous Non-Small Cell CarcinomaStage III Lung Adenocarcinoma AJCC v7Stage III Lung Large Cell Carcinoma AJCC v7+10 more
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Study completedNCT00280150
What this trial is testing

Combination Chemotherapy, Bev, RT, and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
UNC Lineberger Comprehensive Cancer Center 46
Testing effectiveness (Phase 2)Study completedNCT00056004
What this trial is testing

Zileuton in Preventing Lung Cancer in Patients With Bronchial Dysplasia

Who this might be right for
Head and Neck CancerLung Cancer
Barbara Ann Karmanos Cancer Institute 38
Testing effectiveness (Phase 2)Ended earlyNCT03559049
What this trial is testing

Rucaparib and Pembrolizumab for Maintenance Therapy in Stage IV Non-Squamous Non-Small Cell Lung Cancer

Who this might be right for
Stage IV Non-small Cell Lung Cancer
University of Michigan Rogel Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT00188617
What this trial is testing

Phase 2 Study Of Neoadjuvant Iressa Treatment In Stage 1 NSCLC

Who this might be right for
LUNG CANCER
University Health Network, Toronto 35
Next Page